These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Acute liver failure following the use of ecstasy (MDMA)]. Lange-Brock N; Berg T; Müller AR; Fliege H; Neuhaus P; Wiedenmann B; Klapp BF; Mönnikes H Z Gastroenterol; 2002 Aug; 40(8):581-6. PubMed ID: 12297982 [TBL] [Abstract][Full Text] [Related]
3. 3,4-methylenedioxymethamphetamine (MDMA): an important cause of acute hepatitis. Brncić N; Kraus I; Visković I; Mijandrusić-Sincić B; Vlahović-Palcevski V Med Sci Monit; 2006 Nov; 12(11):CS107-9. PubMed ID: 17072276 [TBL] [Abstract][Full Text] [Related]
4. [Variability of the clinical expression of Ecstasy-induced hepatotoxicity]. Núñez O; Bañares R; Barrio J; Menchén L; Diego Ad; Salinero E; Clemente G Gastroenterol Hepatol; 2002 Oct; 25(8):497-500. PubMed ID: 12361531 [TBL] [Abstract][Full Text] [Related]
5. [Acute hepatitis due to ingestion of Ecstasy]. Huarte Muniesa MP; Pueyo Royo AM Rev Esp Enferm Dig; 1995 Sep; 87(9):681-3. PubMed ID: 7577130 [TBL] [Abstract][Full Text] [Related]
6. Ecstasy ingestion and fulminant hepatic failure: liver transplantation to be considered as a last therapeutic option. Garbino J; Henry JA; Mentha G; Romand JA Vet Hum Toxicol; 2001 Apr; 43(2):99-102. PubMed ID: 11308131 [TBL] [Abstract][Full Text] [Related]
7. [Acute liver failure caused by methylenedioxymethamphetamine ('ecstasy')]. de Man RA; Wilson JH; Tjen HS Ned Tijdschr Geneeskd; 1993 Apr; 137(14):727-9. PubMed ID: 8097286 [TBL] [Abstract][Full Text] [Related]
13. [Auxiliary liver transplantation for acute liver failure after intake of 3,4-methylenedioxymethamphetamine ("Ecstasy")]. Hellinger A; Rauen U; de Groot H; Erhard J Dtsch Med Wochenschr; 1997 May; 122(22):716-20. PubMed ID: 9213536 [TBL] [Abstract][Full Text] [Related]
14. [Acute hepatitis due to ecstasy]. Roques V; Perney P; Beaufort P; Hanslik B; Ramos J; Durand L; Le Bricquir Y; Blanc F Presse Med; 1998 Mar; 27(10):468-70. PubMed ID: 9767974 [TBL] [Abstract][Full Text] [Related]
15. Ecstasy: a common cause of severe acute hepatotoxicity. Andreu V; Mas A; Bruguera M; Salmerón JM; Moreno V; Nogué S; Rodés J J Hepatol; 1998 Sep; 29(3):394-7. PubMed ID: 9764985 [TBL] [Abstract][Full Text] [Related]
16. [Hepatitis from ecstasy]. Giner Durán R; Flors H; Millán M; Manzanera R Gastroenterol Hepatol; 1998 Mar; 21(3):158. PubMed ID: 9607299 [No Abstract] [Full Text] [Related]
18. Effect of 3,4-methylenedioxymethamphetamine ("ecstasy") on body temperature and liver antioxidant status in mice: influence of ambient temperature. Carvalho M; Carvalho F; Remião F; de Lourdes Pereira M; Pires-das-Neves R; de Lourdes Bastos M Arch Toxicol; 2002 Apr; 76(3):166-72. PubMed ID: 11967622 [TBL] [Abstract][Full Text] [Related]
19. MDMA-Associated Liver Toxicity: Pathophysiology, Management, and Current State of Knowledge. Cajanding RJM AACN Adv Crit Care; 2019; 30(3):232-248. PubMed ID: 31462520 [TBL] [Abstract][Full Text] [Related]
20. Liver transplantation for the treatment of fulminant hepatic failure induced by the ingestion of ecstasy. Brauer RB; Heidecke CD; Nathrath W; Beckurts KT; Vorwald P; Zilker TR; Schweigart U; Hölscher AH; Siewert JR Transpl Int; 1997; 10(3):229-33. PubMed ID: 9163865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]